A detailed history of Ci Investments Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 5,247 shares of ILMN stock, worth $682,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,247
Previous 5,534 5.19%
Holding current value
$682,424
Previous $760,000 27.89%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.05 - $133.57 $29,001 - $38,334
-287 Reduced 5.19%
5,247 $548,000
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $250,478 - $288,659
1,961 Added 54.88%
5,534 $760,000
Q4 2023

Feb 12, 2024

BUY
$92.79 - $142.53 $1,299 - $1,995
14 Added 0.39%
3,573 $498,000
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $57,751 - $86,213
-448 Reduced 11.18%
3,559 $489,000
Q2 2023

Aug 11, 2023

BUY
$183.43 - $232.67 $330,357 - $419,038
1,801 Added 81.64%
4,007 $751,000
Q1 2023

May 12, 2023

BUY
$193.75 - $232.55 $216,806 - $260,223
1,119 Added 102.94%
2,206 $513,000
Q4 2022

Feb 10, 2023

BUY
$187.24 - $242.74 $108,786 - $141,031
581 Added 114.82%
1,087 $220,000
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $32,610 - $41,848
184 Added 57.14%
506 $97,000
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $101,321 - $205,344
-558 Reduced 63.41%
322 $59,000
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $9,419 - $13,137
31 Added 3.65%
880 $307,000
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $70,497 - $85,631
203 Added 31.42%
849 $323,000
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $262,024 - $339,046
646 New
646 $262,000
Q3 2020

Nov 09, 2020

SELL
$268.51 - $400.74 $27,925 - $41,676
-104 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$256.46 - $373.01 $26,671 - $38,793
104 New
104 $39,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.